Bone Density Loss: Tenofovir has actually been related to a lower in bone mineral density, growing the potential risk of bone problems or fractures. Dolutegravir is an antiviral agent employed for the treatment method of HIV-1 bacterial infections in combination with other antiretroviral brokers. Acquired a wellbeing question? Seek advice https://hivhub.in/product/viropil-tablet/